Results 161 to 170 of about 5,658 (197)
Some of the next articles are maybe not open access.

Farnesylation of Batten Disease CLN3 Protein

Neuropediatrics, 1997
The carboxyl terminal of the predicted amino acid sequence of the Batten disease CLN3 gene protein is CQLS. This motif is expected to be a site for farnesylation at the cysteine residue. In order to determine whether this is indeed farnesylated we have carried out the in-vitro prenylation of tetrapeptides CVLS, CAIL and CQLS using a farnesyl ...
R K, Pullarkat, G N, Morris
openaire   +2 more sources

A diagnostic confidence scheme for CLN3 disease

Journal of Inherited Metabolic Disease, 2021
AbstractOver the past 20 years, diagnostic testing for genetic diseases has evolved, leading to variable diagnostic certainty for individuals included in long‐term natural history studies. Using genotype and phenotype data from an ongoing natural history study of CLN3 disease, we developed a hierarchical diagnostic confidence scheme with three major ...
Margaux C. Masten   +8 more
openaire   +2 more sources

Cross-Species Homology of the CLN3 Gene

Neuropediatrics, 1997
A murine cDNA clone was isolated by screening a mouse cDNA library with the human CLN3 cDNA. Sequence analysis indicates that the corresponding CLN3 proteins are highly homologous. We have compared these with recently identified CLN3 sequences from the dog, the nematode C. elegans, and baker's yeast S. cerevisiae.
P E, Taschner, N, de Vos, M H, Breuning
openaire   +2 more sources

Cerebrospinal Fluid Protein Biomarker Discovery in CLN3

Journal of Proteome Research, 2023
Syndromic CLN3-Batten is a fatal, pediatric, neurodegenerative disease caused by variants in CLN3, which encodes the endolysosomal transmembrane CLN3 protein. No approved treatment for CLN3 is currently available. The protracted and asynchronous disease presentation complicates the evaluation of potential therapies using clinical disease progression ...
An N. Dang Do   +7 more
openaire   +2 more sources

Intracellular Trafficking of the JNCL Protein CLN3

Molecular Genetics and Metabolism, 1999
Juvenile neuronal ceroid lipofuscinosis is a lysosomal storage disease that causes visual impairment, progressive mental deterioration, and eventually death. A predominant 1.02-kb deletion as well as other mutations have been described in the CLN3 gene.
R E, Haskell   +2 more
openaire   +2 more sources

Exogenous Galactosylceramide as Potential Treatment for CLN3 Disease

Annals of Neurology, 2019
ObjectiveCLN3 disease is the commonest of the neuronal ceroid lipofuscinoses, a group of pediatric neurodegenerative disorders. Functions of the CLN3 protein include antiapoptotic properties and facilitating anterograde transport of galactosylceramide from Golgi to lipid rafts.
Sally El‐Sitt   +9 more
openaire   +2 more sources

Reactions of positive ions with ClN3 at 300K

International Journal of Mass Spectrometry, 2011
Abstract The kinetics of eighteen positive ions with chlorine azide (ClN3) have been studied using a selected ion flow tube (SIFT). These measurements allowed for the estimation of both the ionization energy, >930 kJ mol−1 (>9.6 eV), and the proton affinity, 713 ± 41 kJ mol−1, of chlorine azide. Reaction rate constants have been determined.
Nicole Eyet   +3 more
openaire   +1 more source

Photodissociation of ClN3 at 193 and 249 nm

The Journal of Chemical Physics, 1981
Experiments directed toward elucidating the nature of fragments produced by the photodissociation of ClN3 have been performed. The utlraviolet absorption spectrum of this molecule exhibits three features between 300 and 170 nm, with λmax = 250, 205, and <170 nm.
R. D. Coombe   +3 more
openaire   +1 more source

CLN3 disease: Juvenile Dementia

2019
Poster presentation at the Postgraduate Research Poster Competition held by the Graduate School at the Open University on 11th June 2019.
openaire   +1 more source

A suppressor of cln3 for size control

Cell, 1993
D J, Lew, N J, Marini, S I, Reed
openaire   +2 more sources

Home - About - Disclaimer - Privacy